Yahoo
NSE - Delayed Quote INR

Global Health Limited (MEDANTA.NS)

1,270.30 -29.40 (-2.26%)
At close: October 30 at 3:30:02 PM GMT+5:30
Chart Range Bar
Loading chart for MEDANTA.NS
  • Previous Close 1,299.70
  • Open 1,300.00
  • Bid --
  • Ask --
  • Day's Range 1,260.00 - 1,305.00
  • 52 Week Range 956.00 - 1,544.00
  • Volume 95,432
  • Avg. Volume 255,548
  • Market Cap (intraday) 341.142B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) 61.43
  • EPS (TTM) 20.68
  • Earnings Date --
  • Forward Dividend & Yield 0.50 (0.04%)
  • Ex-Dividend Date Aug 14, 2026
  • 1y Target Est 1,592.74

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.

www.medanta.org

12,600

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

MEDANTA.NS
7.11%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

MEDANTA.NS
7.42%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

MEDANTA.NS
66.31%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

MEDANTA.NS
204.37%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 11.59B
Earnings 1.44B
Profit Margin 12.42%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
2B
4B
6B
8B
10B
10.0%
12.0%
14.0%

Analyst Insights

View More

Analyst Price Targets

1,390.00
1,592.74 Average
1,270.30 Current
1,799.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.87%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    46.83B

  • Net Income Avi to Common (ttm)

    5.56B

  • Diluted EPS (ttm)

    20.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.3B

  • Total Debt/Equity (mrq)

    29.87%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: